Skip to content

Clinical Efficacy Evaluation and Mechanism Study of Acupuncture Treatment for Cervical Dystonia

Clinical Efficacy Evaluation and Mechanism Study of Acupuncture Treatment for Cervical Dystonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000503
Enrollment
Unknown
Registered
2024-09-29
Start date
2023-11-14
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dystonia

Interventions

Western medicine section:Inject freeze-dried crystal botulinum toxin type A
Acupuncture and moxibustion group:electric acupuncture

Sponsors

The First Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the diagnostic criteria of spastic torticollis; 2)Age 16-65 years old gender is not limited; 3) The course of disease is less than or equal to 1 year; 4) If the oral antispasticity drug is not effective at least 3 months from the last oral drug treatment; 5)All patients had not received local injection of botulinum toxin type A before or more than 3 months after the last botulinum toxin treatment could be enrolled in the study; 6) Voluntarily sign the informed consent of the trial and can cooperate with and adhere to acupuncture treatment. Note: Only those with the above 6 items can be included in this study.

Exclusion criteria

Exclusion criteria: 1) If the head MRI or CT cervical CT or plain film examination found that there are organic diseases of the skull and neck; 2) Secondary spasmodic torticollis and other dystonic diseases caused by drugs injuries tumors etc.; 3) Patients with severe spastic torticollis were excluded; 4) The interval between the last injection of Botox is less than 3 months or it is still effective. 5)Patients who had received selective radiculotomy cervical muscle amputation and pallidectomy were not included in this study; Have serious heart liver lung kidney and other internal diseases. Note: Patients meeting any of the above criteria were excluded.

Design outcomes

Primary

MeasureTime frame
Tsui scale;Ultrasonics;fMRI;West Toronto spastic Torticollis Scale;Hospital Anxiety and Depression Scale;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index Scale;Surface electromyography;

Countries

China

Contacts

Public ContactZhang Jinjing

The First Affiliated Hospital of Anhui University of Chinese Medicine

15922410659@139.com15922410659

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026